Abeona Therapeutics Receives FDA Fast Track Designation for ABO-202 AAV9 Gene Therapy
Abeona Therapeutics (NASDAQ:ABEO) has announced that the US Food and Drug Administration (FDA) has granted the company fast track designation...
Mesoblast and JCR Pharmaceuticals Expand Japan License Agreement
Mesoblast (NASDAQ:MESO, ASX:MSB) has announced it has expanded its partnership with JCR Pharmaceuticals for its use of mesenchymal stem cells...
Ziopharm Oncology Announces FDA Clearance of IND for Sleeping Beauty TCR-T Cell Therapy Trial
Ziopharm Oncology (NASDAQ:ZIOP) has announced that its investigational new drug (IND) application which was submitted by the National Cancer Institute...
Homology Medicines Initiates Phase 1/2 Study for HMI-102 Gene Therapy Candidate for Adults with PKU
Homology Medicines (NASDAQ:FIXX) has announced it has started enrolling of its Phase 1/2 pheNIX trial for HMI-102, a gene therapy...
Adverum Biotechnologies Doses First Patient in Second Cohort of OPTIC Phase 1 Clinical Trial of ADVM-022
Adverum Biotechnologies (NASDAQ:ADVM) has announced it has dosed the first patient in its second cohort of the ongoing OPTIC phase...
Organovo Collaborates With MCRI and Leiden University Medical Center to Develop Stem Cell-Based Bioprinted Tissue Treatments
Organovo Holdings (NASDAQ:ONVO) has announced a collaboration with the Murdoch Children’s Research ?Institute, The Royal Children’ Hospital in Melbourne, Australia...
Fibrocell Receives FDA Regenerative Medicine Advanced Therapy Designation for FCX-007 Gene Therapy
Fibrocell Science (NASDAQ:FCSC) has announced that the US Food and Drug Administration (FDA) has granted the company Regenerative Medicine Advanced...